News Headlines

  1. ScaleReady Announces A G-Rex® Grant Has Been Awarded To Sonoma Biotherapeutics 11/3/2025

    ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Sonoma Biotherapeutics has been awarded a $300,000 G-Rex® Grant.

  2. Lilly Plans To Build A New $3B Facility To Boost Oral Medicine Manufacturing Capacity In Europe For Patients Worldwide 11/3/2025

    Eli Lilly and Company (NYSE: LLY) announced today plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands, located within the Leiden Bio Science Park. This major project will expand Lilly's capacity to produce oral medicines and strengthen the company's global supply chain.

  3. Ajinomoto Co., Inc. Enters Licensing Agreement With Astellas Pharma Inc. For Biopharmaceutical Development And Manufacturing Technology 10/31/2025

    Ajinomoto Co., Inc. (“Ajinomoto Co.”) has signed a licensing agreement with Astellas Pharma Inc. (“Astellas”) for the use of AJICAP—a proprietary antibody-drug conjugate (ADC) development and manufacturing technology—as part of its CDMO (contract development and manufacturing organization) business for biopharmaceutical development.

  4. IntoCell And Xcellon Biologics Announce MOU To Expand Access To Next-Generation ADC Technologies 10/31/2025

    IntoCell Inc. (KOSDAQ: 287840), a biotechnology company developing next-generation payload and linker technologies for antibody–drug conjugates (ADCs), and Xcellon Biologics, a U.S.-based contract development and manufacturing organization (CDMO) specializing in ADCs and complex biologics, today announced a strategic collaboration to advance ADC development and manufacturing.

  5. Bioharvest Sciences Announces Strategic CDMO Partnership To Revolutionize Saffron Compound Production With Botanical Synthesis 10/30/2025

    BioHarvest Sciences Inc. (“BioHarvest” or the “Company”), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced it has entered into a strategic CDMO agreement with Saffron Tech, a company pioneering advanced cultivation methods for saffron — one of the world’s most valuable and health-promoting botanicals – to develop and commercialize saffron-derived botanical compounds using BioHarvest’s patented Botanical Synthesis platform.

  6. Piramal Pharma Solutions Formalizes Partnership With IntoCell, Expanding Its Payload-Linker Platform And Bioconjugate Capabilities 10/30/2025

    Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), has signed a Memorandum of Understanding (MOU) to solidify its strategic partnership and explore potential collaboration opportunities in ADC development with IntoCell Inc. (KOSDAQ: 287840), a leading Korean biotechnology company specializing in innovative antibody-drug conjugate (ADC) linker and payload platform technologies.

  7. SK pharmteco And LOTTE BIOLOGICS Sign Strategic Partnership To Strengthen Global ADC CDMO Capabilities 10/29/2025

    SK pharmteco and LOTTE BIOLOGICS have announced that they have signed a Letter of Intent (LOI) for a strategic collaboration to strengthen their competitiveness in the global antibody-drug conjugate (ADC) market.

  8. Serán Bioscience Expands Commercial Manufacturing With New 100,000 Sq. Ft. Campus In Bend, Oregon 10/29/2025

    Serán BioScience, LLC, a leading science-driven drug development partner, today announced the completion of two of the three new buildings and commencement of construction of the third facility for of its new 100,000 ft2 commercial manufacturing campus in Bend, Oregon. The new campus will encompass a 50,000 ft2 manufacturing facility, complemented by an adjacent 50,000 ft2 space dedicated to specialized packaging and supply chain operations. The expansion marks a significant milestone in Serán’s mission to provide fully integrated support from first-in-human (FiH) trials through commercial-scale production of small-molecule therapeutics.

  9. Owen Mumford Launches EcoSafe® Safety Syringe Platform – Smarter For Budgets And Kinder To The Planet 10/29/2025

    Oxford - Medical device expert Owen Mumford has extended its 1ml safety syringe platform by adding a companion reusable autoinjector.

  10. IASO Bio Partners With Korea's GC Cell To Bring CAR-T Therapy To Korea 10/29/2025

    Nanjing IASO Biotechnology ("IASO Bio"), today announced that it has signed an agreement with Korea's GC Cell to introduce the CAR-T therapy "Fucaso" (Equecabtagene Autoleucel) to the South Korean market for the treatment of multiple myeloma.